Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers
Jennifer W. Evans(National Institutes of Health), Carlos A. Zarate(National Institute of Mental Health)
Cited by 9
Related Papers
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser <i>v.</i> mood stabiliser alone
|The British Journal of Psychiatry|2004|328
ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing
|Translational Psychiatry|2020|237
12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive Disorder
|Neuropsychopharmacology|2013|78
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
|Molecular Psychiatry|2022|71